Cadrenal Therapeutics Files 8-K: Material Agreement & Other Events
Ticker: CVKD · Form: 8-K · Filed: Mar 4, 2025 · CIK: 1937993
Sentiment: neutral
Topics: material-agreement, corporate-events
Related Tickers: CADR
TL;DR
CADR filed an 8-K for a material agreement & other events. Details pending.
AI Summary
On March 3, 2025, Cadrenal Therapeutics, Inc. entered into a material definitive agreement. The company also reported other events and filed financial statements and exhibits. The specific details of the agreement and the nature of the other events are not fully disclosed in this filing excerpt.
Why It Matters
This filing indicates significant corporate activity for Cadrenal Therapeutics, including a new material agreement, which could impact its business operations and future prospects.
Risk Assessment
Risk Level: medium — The filing indicates a material definitive agreement, which could represent significant opportunities or risks for the company, but the lack of specific details makes the immediate impact uncertain.
Key Players & Entities
- Cadrenal Therapeutics, Inc. (company) — Registrant
- March 3, 2025 (date) — Date of earliest event reported
FAQ
What is the nature of the material definitive agreement entered into by Cadrenal Therapeutics?
The filing states that Cadrenal Therapeutics, Inc. entered into a material definitive agreement on March 3, 2025, but the specific terms and counterparty are not detailed in this excerpt.
What other events are reported in this 8-K filing?
The filing indicates 'Other Events' were reported by Cadrenal Therapeutics, Inc., alongside the material definitive agreement and financial statements/exhibits.
When was this 8-K filing submitted?
This 8-K filing was submitted on March 4, 2025.
What is Cadrenal Therapeutics, Inc.'s principal executive office address?
Cadrenal Therapeutics, Inc.'s principal executive offices are located at 822 A1A North, Suite 306, Ponte Vedra, Florida 32082.
What is the SIC code for Cadrenal Therapeutics, Inc.?
The Standard Industrial Classification (SIC) code for Cadrenal Therapeutics, Inc. is 2834, which corresponds to Pharmaceutical Preparations.
Filing Details
This Form 8-K (Form 8-K) was filed with the SEC on March 4, 2025 regarding Cadrenal Therapeutics, Inc. (CVKD).